At SoCal Biosciences, we are committed to upholding the highest standards of quality and integrity in our research services. In line with this commitment, we are on track to achieve Good Laboratory Practice (GLP) compliance by the second quarter of 2025.
GLP compliance is a set of stringent regulations that govern nonclinical laboratory studies, ensuring the reliability and credibility of data submitted for regulatory evaluations. By adhering to GLP standards, we aim to provide our clients with data of the highest quality, facilitating seamless progression through the regulatory approval process.
Our journey toward GLP compliance involves implementing robust quality management systems, comprehensive personnel training programs, meticulous documentation practices, and regular internal audits. These measures are designed to ensure that all aspects of our research operations meet or exceed the regulatory requirements outlined by authorities such as the U.S. Food and Drug Administration (FDA).
We understand the critical importance of GLP compliance in drug development and other scientific endeavors. By Q2 2025, our GLP-compliant services will be available to support your nonclinical research needs, providing you with confidence in the data’s accuracy and regulatory acceptance.
Partner with SoCal Biosciences for your research projects and benefit from our unwavering dedication to excellence, compliance, and scientific integrity.
Join leading researchers and drug developers who trust our bioanalytical CRO expertise. Receive exclusive content, industry insights, and innovative methodologies straight to your inbox.